How Roche’s new test for Alzheimer’s diagnosis works
A second blood test developed by Roche and Eli Lilly has obtained CE marking and can be used to confirm or exclude Alzheimer’s already in the early stages of cognitive decline, reducing the need for invasive and costly examinations. All the details.
